| Recruiting | Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D NCT07491848 | Research Center of Periodontal-Systemic Interactions | — |
| Not Yet Recruiting | Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France NCT07038863 | Hospices Civils de Lyon | N/A |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants NCT06740474 | Assembly Biosciences | Phase 1 |
| Active Not Recruiting | A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D NCT06505928 | Shanghai HEP Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Respon NCT06504485 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensa NCT06397859 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Recruiting | HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection NCT06264583 | University Hospital, Bonn | — |
| Recruiting | Standardising Care for Hepatitis Delta in the Netherlands NCT05903742 | Erasmus Medical Center | — |
| Recruiting | DELTA DESCRIBE: the French Collaborative Project NCT05936073 | University Hospital, Limoges | — |
| Recruiting | Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy NCT06122285 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Unknown | HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV NCT05928000 | University of Athens | — |
| Completed | Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in Italy NCT05962307 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Unknown | A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection NCT05467553 | National Taiwan University Hospital | Phase 2 |
| Unknown | Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict S NCT05394623 | The First Affiliated Hospital with Nanjing Medical University | — |
| Not Yet Recruiting | Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China NCT05451082 | Lai Wei | — |
| Completed | Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hep NCT06360484 | National Center for Gastroentestinal and Liver Disease | — |
| Unknown | Disease Loads and Status of Treatment NCT05264272 | National Taiwan University Hospital | — |
| Active Not Recruiting | Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) NCT04863703 | Hannover Medical School | — |
| Terminated | A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With NCT04847440 | Antios Therapeutics, Inc | Phase 2 |
| Unknown | Epidemiology of Hepatitis B, C and Delta in Reunion Island NCT03362866 | Centre Hospitalier Universitaire de la Réunion | — |
| Completed | Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon NCT03600714 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHe NCT05002907 | Centre Hospitalier de Cayenne | — |
| Terminated | Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV) NCT02577029 | Arrowhead Pharmaceuticals | Phase 2 |
| Completed | Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir NCT02511431 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Mother-to-child Hepatitis D Transmission NCT02044055 | Hopital Lariboisière | — |
| Completed | The Hepatitis Delta International Network NCT02375906 | HepNet Study House, German Liverfoundation | — |
| Completed | Lonafarnib for Chronic Hepatitis D NCT01495585 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Terminated | Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV) NCT01316185 | Eiger BioPharmaceuticals | Phase 1 |
| Completed | HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis NCT00932971 | HepNet Study House, German Liverfoundation | Phase 2 |
| Completed | Pegylated Interferon to Treat Chronic Hepatitis D NCT00023322 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Recruiting | Evaluation of Patients With Liver Disease NCT00001971 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |